Continue Reading on TOI App
Open
OPEN APP

Panacea starts Sputnik production

NEW DELHI:

Panacea Biotec

and

Russia

’s sovereign wealth fund,

Russian Direct Investment Fund

(

RDIF

) announced the start of production of the Sputnik V vaccine.


The commercial manufacture will be starting in summer. Under a tie-up, RDIF and

Panacea

have agreed to produce 100 million doses per year of the vaccine. Efficacy of Sputnik V is 97.6%.
Continue Reading
Follow Us On Social Media
end of article
More Trending Stories
Visual Stories
More Visual Stories
UP NEXT
Do Not Sell Or Share My Personal Information